Organization
Hospital Universitario 12 de Octubre, Madrid, Spain
6 abstracts
Abstract
Efficacy and safety of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: DESTINY-PanTumor02 (DP-02) interim results.Org: Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, Seoul National University College of Medicine, Seoul, Korea, Republic of (South), Cancer Center Clínica Universidad de Navarra, Madrid, Spain, Maria Sklodowska-Curie National Research Institute and Oncology Centre (MSCI), Warsaw, Poland, Hospital Clínico San Carlos and IdISSC, Madrid, Spain,
Abstract
Sacituzumab govitecan (SG) vs docetaxel (doc) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC) previously treated with platinum (PT)-based chemotherapy (chemo) and PD(L)-1inhibitors (IO): Primary results from the phase 3 EVOKE-01 study.Org: Hospital Universitario 12 de Octubre, Madrid, Spain, Hospital Universitari i Politécnic La Fe de Valencia, Valencia, Spain, Henry Dunant Hospital Center, Athens, Greece, Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology, Barcelona, Spain, Asklepios Lung Clinic, German Center for Lung Research (DZL), Munich-Gauting, Germany,
Abstract
Safety, efficacy and biomarker data in non-small cell lung cancer patients treated with the anti-IL1RAP antibody nadunolimab in combination with platinum doublet.Org: Hospital Universitario 12 de Octubre, Madrid, Spain, Centre Hospitalier Universitaire de Liège, Liège, Belgium, Department of Pulmonology Medical Academy Lithuania University of Health Sciences, Kaunas, Lithuania, National Cancer Institute, Vilnius, Lithuania, Riga East Clinical University Hospital, Riga, Latvia,
Abstract
ASSOCIATED FACTORS WITH MORTALITY AND DERIVATION OF A SIMPLE 5-FACTORS TO PREDICT MORTALITY IN SSC-PATIENTS IN THE EUSTAR COHORT Org: Rheumatology A, Cochin Hospital, Paris Descartes University, Paris, France, Université Paris XIII, Bobigny, Bobigny, CHU Lille, Lille, France, Technion–Institute of Technology, Haifa, Israel, University of Lübeck, Lübeck, Germany,
Abstract
BASELINE DEMOGRAPHICS AND DISEASE CHARACTERISTICS IN SUBJECTS WITH ILD IN A PHASE 2 STUDY TO EVALUATE EFFICACY, SAFETY, AND TOLERABILITY OF MT-7117 IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSISOrg: University of Michigan, Ann Arbor, United States of America, Hospital Universitario 12 de Octubre, Madrid, Spain, Stanford University School of Medicine, Stanford, United States of America, University College London and Royal Free Hospital, London, United Kingdom, IRCCS San Raffaele University Hospital, Milan, Italy,
Abstract
ASSOCIATION STUDY OF GENETIC RISK VARIANTS FOR PSORIASIS IN A LARGE COHORT OF PSORIATIC ARTHRITIS, PSORIASIS AND CONTROLS OF THE SPANISH POPULATION AND ASSOCIATION WITH RELEVANT CLINICAL SUBPHENOTYPES Org: Hospital Clinic i Provincial de Barcelona, Barcelona, Spain, Hospital Universitario Gregorio Marañόn, Madrid, Complejo Hospitalario Juan Canalejo, A Coruña, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, Hospital Universitario de Salamanca, Salamanca,